News
--BioVaxys Technology Corp. is pleased to announce that it has been invited to and joined The Rapid Response Partnership Vehicle, a consortium of large and small biopharma, contractors, government ...
News about Biomedical Advanced Research and Development Authority. Commentary and archival information about Biomedical Advanced Research and Development Authority from The New York Times.
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term ...
The Biomedical Advanced Research and Development Authority (BARDA), ... Biomedical Advanced Research and Development Authority (BARDA), under contract number 75A50124C00040. ...
The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority.
Department of Health and Human Services, valued at $41.9 million, for drug substance engineering and scale-up process validation, long term stability, and commercial readiness in support of its ...
Morningstar brands and products Company Portfolio ...
Article ‘Count’ and ‘Share’ for HHS Biomedical Advanced Research and Development Authority (BARDA) based on listed parameters only. The articles listed below published by authors from HHS ...
VANCOUVER, BC, Nov. 5, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results